Hyperinsulinemic hypoglycemia is a potentially lethal disease caused by inadequate production of insulin by the beta cells of the pancreatic islets of Langerhans. Lethal hypoglycemia and brain damage is a problem especially in infants born with the disease. The major problem of current therapeutic approaches (partial/near total pancreatectomy combined with medical treatment) are the frequently observed severe side effects/morbidity (diabetes, exocrine pancreas insufficiency etc.) since they massively reduce quality of life as well as life expectancy. However, they are considered acceptable in relation to the lethal or debilitating outcome of the disease itself if left untreated.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline